Nagata S - Search Results

1

Elevated serum level of Fas ligand correlates with the asymptomatic stage of human immunodeficiency virus infection.

Bahr GM, Capron A, Dewulf J, Nagata S, Tanaka M, Bourez JM, Mouton Y. Bahr GM, et al. Among authors: nagata s. Blood. 1997 Jul 15;90(2):896-8. Blood. 1997. PMID: 9226197 Free article. No abstract available.

2

Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists.

Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, Ameisen JC. Estaquier J, et al. Among authors: nagata s. Blood. 1996 Jun 15;87(12):4959-66. Blood. 1996. PMID: 8652808 Free article.

3

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

Tanaka M, Suda T, Takahashi T, Nagata S. Tanaka M, et al. Among authors: nagata s. EMBO J. 1995 Mar 15;14(6):1129-35. doi: 10.1002/j.1460-2075.1995.tb07096.x. EMBO J. 1995. PMID: 7536672 Free PMC article.

4

Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand.

Suda T, Tanaka M, Miwa K, Nagata S. Suda T, et al. Among authors: nagata s. J Immunol. 1996 Nov 1;157(9):3918-24. J Immunol. 1996. PMID: 8892623

5

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing.

Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S. Suda T, et al. Among authors: nagata s. J Exp Med. 1997 Dec 15;186(12):2045-50. doi: 10.1084/jem.186.12.2045. J Exp Med. 1997. PMID: 9396774 Free PMC article.

6

Downregulation of Fas ligand by shedding.

Tanaka M, Itai T, Adachi M, Nagata S. Tanaka M, et al. Among authors: nagata s. Nat Med. 1998 Jan;4(1):31-6. doi: 10.1038/nm0198-031. Nat Med. 1998. PMID: 9427603

7

Levels of soluble Fas ligand in myocarditis.

Toyozaki T, Hiroe M, Tanaka M, Nagata S, Ohwada H, Marumo F. Toyozaki T, et al. Among authors: nagata s. Am J Cardiol. 1998 Jul 15;82(2):246-8. doi: 10.1016/s0002-9149(98)00300-2. Am J Cardiol. 1998. PMID: 9678301

8

Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes.

Tanaka M, Suda T, Yatomi T, Nakamura N, Nagata S. Tanaka M, et al. Among authors: nagata s. J Immunol. 1997 Mar 1;158(5):2303-9. J Immunol. 1997. PMID: 9036978

9

Fas ligand in human serum.

Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S. Tanaka M, et al. Among authors: nagata s. Nat Med. 1996 Mar;2(3):317-22. doi: 10.1038/nm0396-317. Nat Med. 1996. PMID: 8612231

10

Human Fas ligand: gene structure, chromosomal location and species specificity.

Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Takahashi T, et al. Among authors: nagata s. Int Immunol. 1994 Oct;6(10):1567-74. doi: 10.1093/intimm/6.10.1567. Int Immunol. 1994. PMID: 7826947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,147 results

Search Page

Filters